Fabio Petrocca

17.6k total citations · 6 hit papers
39 papers, 11.0k citations indexed

About

Fabio Petrocca is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Fabio Petrocca has authored 39 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 15 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Fabio Petrocca's work include MicroRNA in disease regulation (15 papers), CAR-T cell therapy research (13 papers) and Cancer-related molecular mechanisms research (11 papers). Fabio Petrocca is often cited by papers focused on MicroRNA in disease regulation (15 papers), CAR-T cell therapy research (13 papers) and Cancer-related molecular mechanisms research (11 papers). Fabio Petrocca collaborates with scholars based in United States, Italy and Spain. Fabio Petrocca's co-authors include Carlo M. Croce, Stefano Volinia, Rosa Visone, Andrea Vecchione, George A. Calin, Chang‐Gong Liu, Marilena V. Iorio, Massimo Negrini, Stefan Ambs and Robyn L. Prueitt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Nature Communications.

In The Last Decade

Fabio Petrocca

39 papers receiving 10.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A microRNA expression signature of human solid tumors defines cancer gene targets

2006 4.7k citations Stefano Volinia, George A. Calin et al. Proceedings of the National Academy of Sciences profile →
MicroRNA Signatures in Human Ovarian Cancer

2007 1.2k citations Marilena V. Iorio, Rosa Visone et al. Cancer Research profile →
MicroRNA Expression Patterns to Differentiate Pancreatic Adenocarcinoma From Normal Pancreas and Chronic Pancreatitis

2007 939 citations Mark Bloomston, Wendy L. Frankel et al. JAMA profile →
E2F1-Regulated MicroRNAs Impair TGFβ-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer

2008 719 citations Fabio Petrocca, Rosa Visone et al. Cancer Cell profile →
Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer

2008 591 citations Stefan Ambs, Robyn L. Prueitt et al. Cancer Research profile →
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma

2021 236 citations Timothy Campbell, Fabio Petrocca et al. profile →

Peers

Fabio Petrocca

ONCOL

IMMUN

HEMAT

Angelo Veronese Italy

Andreas G. Bader United States

Ramiro Garzon United States

Rosa Visone Italy

Thomas J. Kipps United States

Thórdur Óskarsson Germany

Ulrich H. Weidle Germany

Andrei Thomas‐Tikhonenko United States

Subrata Sen United States

Andrew G. Bert Australia

Angelo Veronese Italy

Fabio Petrocca

7.2k ×0.8

6.5k ×0.8

834 ×0.5

ONCOL

517 ×0.8

IMMUN

166 ×0.4

HEMAT

Citations per year, relative to Fabio Petrocca Fabio Petrocca (= 1×) peers Angelo Veronese

Countries citing papers authored by Fabio Petrocca

Since Specialization

Citations

This map shows the geographic impact of Fabio Petrocca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Petrocca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Petrocca more than expected).

Fields of papers citing papers by Fabio Petrocca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabio Petrocca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Petrocca. The network helps show where Fabio Petrocca may publish in the future.

Co-authorship network of co-authors of Fabio Petrocca

This figure shows the co-authorship network connecting the top 25 collaborators of Fabio Petrocca. A scholar is included among the top collaborators of Fabio Petrocca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabio Petrocca. Fabio Petrocca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abdallah, Maya, Adam Lerner, Fabio Petrocca, et al.. (2024). Febrile neutropenia in patients with Duffy-null–associated neutrophil counts and multiple myeloma or AL amyloidosis. Blood Advances. 8(23). 5935–5938. 1 indexed citations

Raje, Noopur, Nina Shah, Sundar Jagannath, et al.. (2021). Updated Clinical and Correlative Results from the Phase I CRB-402 Study of the BCMA-Targeted CAR T Cell Therapy bb21217 in Patients with Relapsed and Refractory Multiple Myeloma. Blood. 138(Supplement 1). 548–548. 66 indexed citations

Madduri, Deepu, Samir Parekh, Timothy Campbell, et al.. (2021). Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report. Journal of Medical Case Reports. 15(1). 90–90. 4 indexed citations

Shah, Nina, Melissa Alsina, David S. Siegel, et al.. (2018). Initial Results from a Phase 1 Clinical Study of bb21217, a Next-Generation Anti Bcma CAR T Therapy. Blood. 132(Supplement 1). 488–488. 66 indexed citations

Sridhar, Praveen, Rory Kirchner, Zach Herbert, et al.. (2017). Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival. Molecular Cancer Therapeutics. 16(12). 2849–2861. 36 indexed citations

Gilboa-Geffen, Adi, Péter Hamar, Minh T. N. Le, et al.. (2015). Gene Knockdown by EpCAM Aptamer–siRNA Chimeras Suppresses Epithelial Breast Cancers and Their Tumor-Initiating Cells. Molecular Cancer Therapeutics. 14(10). 2279–2291. 69 indexed citations

Petrocca, Fabio, et al.. (2015). miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes. Oncogene. 35(2). 158–172. 101 indexed citations

Petrocca, Fabio, Gabriel Altschuler, Shen Mynn Tan, et al.. (2013). A Genome-wide siRNA Screen Identifies Proteasome Addiction as a Vulnerability of Basal-like Triple-Negative Breast Cancer Cells. Cancer Cell. 24(2). 182–196. 141 indexed citations

Petrocca, Fabio & Judy Lieberman. (2009). Micromanipulating cancer: microRNA-based therapeutics?. RNA Biology. 6(3). 335–340. 28 indexed citations

10.

Petrocca, Fabio & Judy Lieberman. (2009). Chapter 4 Micromanagers of Immune Cell Fate and Function. Advances in immunology. 102. 227–244. 13 indexed citations

11.

Dykxhoorn, Derek M., Huangming Xie, Fengyan Yu, et al.. (2009). miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases. PLoS ONE. 4(9). e7181–e7181. 260 indexed citations

12.

Visone, Rosa, Monica Fedele, Fabio Petrocca, et al.. (2009). Regulation of microRNA expression by HMGA1 proteins. Oncogene. 28(11). 1432–1442. 42 indexed citations

13.

Ambs, Stefan, Robyn L. Prueitt, Ming Yi, et al.. (2008). Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer. Cancer Research. 68(15). 6162–6170. 591 indexed citations breakdown →

14.

Visone, Rosa, Fabio Petrocca, & Carlo M. Croce. (2008). Micro-RNAs in Gastrointestinal and Liver Disease. Gastroenterology. 135(6). 1866–1869. 43 indexed citations

15.

Iorio, Marilena V., Rosa Visone, Gianpiero Di Leva, et al.. (2007). MicroRNA Signatures in Human Ovarian Cancer. Cancer Research. 67(18). 8699–8707. 1199 indexed citations breakdown →

16.

Visone, Rosa, Pierlorenzo Pallante, Andrea Vecchione, et al.. (2007). Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene. 26(54). 7590–7595. 312 indexed citations

17.

Bloomston, Mark, Wendy L. Frankel, Fabio Petrocca, et al.. (2007). MicroRNA Expression Patterns to Differentiate Pancreatic Adenocarcinoma From Normal Pancreas and Chronic Pancreatitis. JAMA. 297(17). 1901–1901. 939 indexed citations breakdown →

18.

Visone, Rosa, Lucia Russo, Pierlorenzo Pallante, et al.. (2007). MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocrine Related Cancer. 14(3). 791–798. 361 indexed citations

19.

Volinia, Stefano, George A. Calin, Chang‐Gong Liu, et al.. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences. 103(7). 2257–2261. 4730 indexed citations breakdown →

20.

Petrocca, Fabio, Dimitrios Iliopoulos, Haiyan Qin, et al.. (2006). Alterations of the Tumor Suppressor Gene ARLTS1 in Ovarian Cancer. Cancer Research. 66(21). 10287–10291. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact